Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats

Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats

The use of cell therapies has recently increased for the treatment of pulmonary diseases. Mesenchymal stem/stromal cells (MSCs) and alveolar type II cells (ATII) are the main cell-based therapies used for the treatment of acute respiratory distress syndrome (ARDS). Many pre-clinical studies have sho...

Full description

Bibliographic Details
Main Authors: Raquel Guillamat-Prats, Marta Camprubí-Rimblas, Ferranda Puig, Raquel Herrero, Neus Tantinyà, Anna Serrano-Mollar, Antonio Artigas
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cells
Subjects:
cell therapy
alveolar type II cells
mesenchymal stem cells
acute lung injury
ARDS
ALI
Online Access:https://www.mdpi.com/2073-4409/9/8/1816

Similar Items

Similar Items